159 related articles for article (PubMed ID: 38783308)
1. Navigating the nexus between British Columbia's public consumption and decriminalization policies of illegal drugs.
Ali F; Law J; Russell C; Crépault JF; Goulão JC; Lock K; Rehm J
Health Res Policy Syst; 2024 May; 22(1):60. PubMed ID: 38783308
[TBL] [Abstract][Full Text] [Related]
2. People who use drugs' prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study.
Xavier JC; McDermid J; Buxton J; Henderson I; Streukens A; Lamb J; Greer A
Int J Drug Policy; 2024 Mar; 125():104354. PubMed ID: 38402802
[TBL] [Abstract][Full Text] [Related]
3. Awareness and knowledge of drug decriminalization among people who use drugs in British Columbia: a multi-method pre-implementation study.
Greer A; Xavier J; Loewen OK; Kinniburgh B; Crabtree A
BMC Public Health; 2024 Feb; 24(1):407. PubMed ID: 38331771
[TBL] [Abstract][Full Text] [Related]
4. "2.5 g, I could do that before noon": a qualitative study on people who use drugs' perspectives on the impacts of British Columbia's decriminalization of illegal drugs threshold limit.
Ali F; Russell C; Greer A; Bonn M; Werb D; Rehm J
Subst Abuse Treat Prev Policy; 2023 Jun; 18(1):32. PubMed ID: 37322496
[TBL] [Abstract][Full Text] [Related]
5. Policy actor views on structural vulnerability in harm reduction and policymaking for illegal drugs: A qualitative study.
Gehring ND; Speed KA; Wild TC; Pauly B; Salvalaggio G; Hyshka E
Int J Drug Policy; 2022 Oct; 108():103805. PubMed ID: 35907373
[TBL] [Abstract][Full Text] [Related]
6. Zoned Out: "NIMBYism", addiction services and municipal governance in British Columbia.
Bernstein SE; Bennett D
Int J Drug Policy; 2013 Nov; 24(6):e61-5. PubMed ID: 23680227
[TBL] [Abstract][Full Text] [Related]
7. "There are solutions and I think we're still working in the problem": The limitations of decriminalization under the good Samaritan drug overdose act and lessons from an evaluation in British Columbia, Canada.
Xavier J; Greer A; Pauly B; Loyal J; Mamdani Z; Ackermann E; Barbic S; Buxton JA
Int J Drug Policy; 2022 Jul; 105():103714. PubMed ID: 35561485
[TBL] [Abstract][Full Text] [Related]
8. Decriminalization thresholds for drug possession: A multi-criteria policy analysis framework.
McAdam E; Small W; Mullins G; Graham B; Greer A; Winder N; DeBeck K
Int J Drug Policy; 2023 Sep; 119():104126. PubMed ID: 37454608
[TBL] [Abstract][Full Text] [Related]
9. Drug policy and Collective Health: necessary dialogues.
Gomes-Medeiros D; Faria PH; Campos GWS; Tófoli LF
Cad Saude Publica; 2019 Jul; 35(7):e00242618. PubMed ID: 31365702
[TBL] [Abstract][Full Text] [Related]
10. Estimating the economic value of British Columbia's domestic cannabis market: implications for provincial cannabis policy.
Werb D; Nosyk B; Kerr T; Fischer B; Montaner J; Wood E
Int J Drug Policy; 2012 Nov; 23(6):436-41. PubMed ID: 23085258
[TBL] [Abstract][Full Text] [Related]
11. 'Drug decriminalization' in Canada: a plea for a nuanced, evidence-informed, and realistic approach towards improved health outcomes.
Fischer B
Can J Public Health; 2023 Dec; 114(6):943-946. PubMed ID: 37462843
[TBL] [Abstract][Full Text] [Related]
12. Decriminalization or police mission creep? Critical appraisal of law enforcement involvement in British Columbia, Canada's decriminalization framework.
Michaud L; McDermid J; Bailey A; Singh Kelsall T
Int J Drug Policy; 2024 Jun; 129():104478. PubMed ID: 38879942
[TBL] [Abstract][Full Text] [Related]
13. The impact of drug policy liberalisation on willingness to seek help for problem drug use: A comparison of 20 countries.
Benfer I; Zahnow R; Barratt MJ; Maier L; Winstock A; Ferris J
Int J Drug Policy; 2018 Jun; 56():162-175. PubMed ID: 29731288
[TBL] [Abstract][Full Text] [Related]
14. Peer engagement barriers and enablers: insights from people who use drugs in British Columbia, Canada.
Greer AM; Amlani A; Burmeister C; Scott A; Newman C; Lampkin H; Pauly B; Buxton JA
Can J Public Health; 2019 Apr; 110(2):227-235. PubMed ID: 30610564
[TBL] [Abstract][Full Text] [Related]
15. Canada moving backwards on illegal drugs.
Hyshka E; Butler-McPhee J; Elliott R; Wood E; Kerr T
Can J Public Health; 2012; 103(2):125-7. PubMed ID: 22530535
[TBL] [Abstract][Full Text] [Related]
16. Atmospheric pressure: Russian drug policy as a driver for violations of the UN Convention against Torture and the International Covenant on Economic, Social and Cultural Rights.
Golichenko M; Sarang A
Health Hum Rights; 2013 Jun; 15(1):E135-43. PubMed ID: 25006082
[TBL] [Abstract][Full Text] [Related]
17. Harm Reduction Services in Ottawa: The Culture of Drug Use.
Haines M; O'Byrne P
Res Theory Nurs Pract; 2020 May; 34(2):188-202. PubMed ID: 32457123
[TBL] [Abstract][Full Text] [Related]
18. The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbia.
Morgan S; Cunningham C
Healthc Policy; 2008 Feb; 3(3):54-63. PubMed ID: 19305768
[TBL] [Abstract][Full Text] [Related]
19. The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbia.
Morgan S; Cunningham C
Healthc Policy; 2008 Feb; 3(3):e128-53. PubMed ID: 19305760
[TBL] [Abstract][Full Text] [Related]
20. "It's an emotional roller coaster… But sometimes it's fucking awesome": Meaning and motivation of work for peers in overdose response environments in British Columbia.
Pauly BB; Mamdani Z; Mesley L; McKenzie S; Cameron F; Edwards D; Howell A; Knott M; Scott T; Seguin R; Greer AM; Buxton JA
Int J Drug Policy; 2021 Feb; 88():103015. PubMed ID: 33176249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
